Legal Representation
Attorney
Sona Dalal
USPTO Deadlines
Application History
11 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 8, 2023 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Nov 7, 2023 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Nov 7, 2023 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jun 8, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Jun 8, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Mar 12, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 12, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 12, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 21, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 7, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 6, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Stem cells for medical purposes; pharmaceuticals derived from stem cells and used for anti-aging, age reversal, and for the treatment of cardiac disease, neurodegenerative disease, musculoskeletal trauma, neurological trauma, type 1 diabetes, liver disease, lung disease, pancreatic disease, psychosis, and psychiatric disorder; Nutraceuticals for use as a dietary supplement; Nutraceuticals for the treatment of or reversal of aging and age-related disease; nutraceuticals for use as a dietary supplement for the intended benefit of reversing the aging process and age-related disease; Nutraceuticals derived from stem cells and for use as a dietary supplement for the intended benefit of reversing the aging process and age-related disease; Nutraceuticals for use as a dietary supplement for the intended benefit of anti-aging, age reversal, treatment of cardiac disease, neurodegenerative disease, musculoskeletal trauma, neurological trauma, type 1 diabetes, liver disease, lung disease, pancreatic disease, psychosis, and psychiatric disorder; Nutraceuticals derived from stem cells for use as a dietary supplement for the intended benefit of anti-aging, age reversal, treatment of cardiac disease, neurodegenerative disease, musculoskeletal trauma, neurological trauma, type 1 diabetes, liver disease, lung disease, pancreatic disease, psychosis, and psychiatric disorder
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005